STOCK TITAN

Vanguard (CI) reports 10.03% stake in Cigna after internal realignment

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Cigna Group disclosed that The Vanguard Group filed an amendment to its Schedule 13G reporting beneficial ownership of 26,445,689 shares of common stock, representing 10.03% of the class.

The filing shows shared voting power of 2,785,837 shares and shared dispositive power over 26,445,689 shares. The filer notes an internal realignment effective January 12, 2026 that will lead certain Vanguard subsidiaries to report beneficial ownership separately.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports a 10.03% stake in Cigna with shared voting and dispositive authority.

The Schedule 13G/A lists 26,445,689 shares beneficially owned, with 2,785,837 shares of shared voting power and shared dispositive power reported at 26,445,689. This is an ownership disclosure under passive/investment manager rules.

The filing also documents a January 12, 2026 internal realignment at Vanguard that may lead to disaggregated reporting by subsidiaries; timing and scope of any separate subsidiary filings are not stated.






02/27/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting. In accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/05/2026

FAQ

What stake does The Vanguard Group report in Cigna (CI)?

The Vanguard Group reports beneficial ownership of 26,445,689 shares, representing 10.03% of Cigna's common stock. This figure is shown in Item 4 as the amount beneficially owned and the percent of class.

What voting and dispositive powers does Vanguard report for CI shares?

The filing shows shared voting power of 2,785,837 shares and shared dispositive power over 26,445,689 shares. Sole voting and sole dispositive powers are reported as zero.

Does the filing say Vanguard will change how it reports ownership?

Yes. It states Vanguard underwent an internal realignment effective January 12, 2026, after which certain subsidiaries are expected to report beneficial ownership separately in reliance on SEC Release No. 34-39538.

Who signed the Schedule 13G/A for Vanguard on the CI filing?

The amendment is signed by Ashley Grim, titled Head of Global Fund Administration, with a signature date of 03/05/2026, certifying the reported ownership and related disclosures.
Cigna Group

NYSE:CI

CI Rankings

CI Latest News

CI Latest SEC Filings

CI Stock Data

74.81B
257.82M
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
BLOOMFIELD